Kian P. Koh, Ph.D. - Publications
Affiliations: | 2004 | Yale University, New Haven, CT |
Area:
Pharmacology, ImmunologyYear | Citation | Score | |||
---|---|---|---|---|---|
2023 | Chui JS, Izuel-Idoype T, Qualizza A, de Almeida RP, Piessens L, van der Veer BK, Vanmarcke G, Malesa A, Athanasouli P, Boon R, Vriens J, van Grunsven L, Koh KP, Verfaillie CM, Lluis F. Osmolar Modulation Drives Reversible Cell Cycle Exit and Human Pluripotent Cell Differentiation via NF-κВ and WNT Signaling. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2307554. PMID 38037844 DOI: 10.1002/advs.202307554 | 0.332 | |||
2006 | Yi T, Cuchara L, Wang Y, Koh KP, Ranjbaran H, Tellides G, Pober JS, Lorber MI. Human allograft arterial injury is ameliorated by sirolimus and cyclosporine and correlates with suppression of interferon-gamma. Transplantation. 81: 559-66. PMID 16495804 DOI: 10.1097/01.Tp.0000198737.12507.19 | 0.483 | |||
2004 | Koh KP, Wang Y, Yi T, Shiao SL, Lorber MI, Sessa WC, Tellides G, Pober JS. T cell-mediated vascular dysfunction of human allografts results from IFN-gamma dysregulation of NO synthase. The Journal of Clinical Investigation. 114: 846-56. PMID 15372109 DOI: 10.1172/Jci21767 | 0.68 | |||
2004 | Choi J, Enis DR, Koh KP, Shiao SL, Pober JS. T lymphocyte-endothelial cell interactions Annual Review of Immunology. 22: 683-709. PMID 15032593 DOI: 10.1146/Annurev.Immunol.22.012703.104639 | 0.361 | |||
2004 | Koh KP, Wang Y, Yi T, Lorber MI, Sessa WC, Tellides G, Pober JS. HUMAN ALLOGENEIC T CELL-MEDIATED VASCULAR DYSFUNCTION DEPENDS ON INTERFERON-GAMMA Cardiovascular Pathology. 13: 9. DOI: 10.1016/J.Carpath.2004.03.021 | 0.743 | |||
Show low-probability matches. |